Search Count: 115
 |
Crystal Structure Of Sars-Cov-2 Mpro Mutant E166A With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2025-03-19 Classification: VIRAL PROTEIN, HYDROLASE/HYDROLASE INHIBITOR Ligands: GOL, V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro Mutant E166V With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2025-03-19 Classification: VIRAL PROTEIN, HYDROLASE/HYDROLASE INHIBITOR Ligands: GOL, V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro Mutant L50F E166V With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.84 Å Release Date: 2025-03-19 Classification: VIRAL PROTEIN, HYDROLASE/HYDROLASE INHIBITOR Ligands: DMS, V2M, CL |
 |
Organism: Enterovirus d68
Method: X-RAY DIFFRACTION Resolution:1.97 Å Release Date: 2025-01-15 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: AG7 |
 |
Organism: Enterovirus d68
Method: X-RAY DIFFRACTION Resolution:1.97 Å Release Date: 2025-01-15 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: XNV, NA |
 |
Organism: Enterovirus d68
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2025-01-15 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: UED |
 |
Crystal Structure Of Enterovirus 68 3C Protease C147A Mutant With 3B3C Peptide At 2.00 Angstroms
Organism: Human enterovirus d68
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2024-09-18 Classification: VIRAL PROTEIN,HYDROLASE |
 |
Crystal Structure Of Sars Cov-2 Mpro Mutant L141R With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2024-02-07 Classification: VIRAL PROTEIN Ligands: DMS, V2M, NA |
 |
Crystal Structure Of Sars Cov-2 Mpro Mutant N142P With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.75 Å Release Date: 2024-02-07 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: V2M |
 |
Crystal Structure Of Sars Cov-2 Mpro Mutant L50F With Nirmatrelvir Captured In Two Conformational States
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2024-02-07 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: DMS, 4WI, NA, CL |
 |
Crystal Structure Of Enterovirus 68 3C Protease Inactive Mutant C147A At 1.8 Angstroms.
Organism: Enterovirus d68
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2024-01-10 Classification: VIRAL PROTEIN |
 |
Crystal Structure Of Sars Cov-2 Mpro With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2023-03-29 Classification: VIRAL PROTEIN/HYDROLASE/INHIBITOR Ligands: GOL, V2M, DMS |
 |
Crystal Structure Of Porcine Deltacoronavirus (Hku-15) Mpro With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Porcine deltacoronavirus
Method: X-RAY DIFFRACTION Resolution:2.45 Å Release Date: 2023-03-29 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: V2M, GOL, DMS |
 |
Crystal Structure Of Beluga Whale Gammacoronavirus Sw1 Mpro With Gc-376 Captured In Two Conformational States
Organism: Beluga whale coronavirus sw1
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2023-03-29 Classification: VIRAL PROTEIN Ligands: K36, B1S, GOL |
 |
Organism: Beluga whale coronavirus sw1
Method: X-RAY DIFFRACTION Resolution:2.12 Å Release Date: 2023-03-29 Classification: VIRAL PROTEIN Ligands: SO4, PEG |
 |
Organism: Hepacivirus c
Method: X-RAY DIFFRACTION Resolution:1.89 Å Release Date: 2022-08-31 Classification: HYDROLASE/INHIBITOR Ligands: EDO, ZN, ZJP, SO4 |
 |
Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp4/5 (P6-P1)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR |
 |
Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp5/6 (P6-P1)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR |
 |
Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp6/7 (P6-P1)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.21 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR |
 |
Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp7/8 (P6-P1)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.02 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR |